88
Participants
Start Date
February 4, 2022
Primary Completion Date
March 30, 2024
Study Completion Date
May 30, 2024
Micronized Purified Flavonoid Fraction
After randomization (1:1 with stratification by centre) patients will receive 1000 mg of oral MPFF (Venixxa, one 500mg tablet BID) for 6 months, in addition to their usual PTS and DVT treatment
Placebo
After randomization (1:1 with stratification by centre) patients will receive an oral placebo (one tablet BID) for 6 months, in addition to their usual PTS and DVT treatment
Vancouver General Hospital, Vancouver
Queen Elizabeth II Health Sciences Centre, Halifax
Hamilton General Hospital, Hamilton
Ottawa Hospital Research Institute, Ottawa
Sunnybrook Health Sciences Centre, Toronto
Toronto General Hospital, Toronto
Sir Mortimer B. Davis - Jewish General Hospital, Montreal
Sir Mortimer B. Davis - Jewish General Hospital
OTHER